A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss
Completed
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2
1999-05-01
The purpose of this study is to determine whether a high-quality protein food supplement will
help HIV-positive patients maintain, and possibly gain, muscle mass.
Many HIV-positive patients lose weight that they are then unable to regain. This may be
because patients are not eating enough protein or are not eating the right kinds of protein.
The protein eaten in foods (such as meat, eggs, or beans) may not be able to make up for the
amount of protein lost due to HIV infection. This study gives patients high-quality protein
food supplements to help them maintain and/or gain weight.
Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants
Completed
National Center for Research Resources (NCRR)
Phase 3
1999-07-01
This large multicenter double-masked clinical trial tested whether supplementation of
standard neonatal parenteral nutrition with glutamine would reduce the risk of death or
late-onset sepsis in extremely-low-birth-weight (ELBW, less than or equal to 1000 gm)
infants. Neonates with birth weights of 401-1000gm were randomized to standard TrophAmine or
TrophAmine supplemented with glutamine before 72 hours and continued until the infants are
tolerating full enteral feedings.
Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants
Completed
NICHD Neonatal Research Network
Phase 3
1999-07-01
This large multicenter double-masked clinical trial tested whether supplementation of
standard neonatal parenteral nutrition with glutamine would reduce the risk of death or
late-onset sepsis in extremely-low-birth-weight (ELBW, less than or equal to 1000 gm)
infants. Neonates with birth weights of 401-1000gm were randomized to standard TrophAmine or
TrophAmine supplemented with glutamine before 72 hours and continued until the infants are
tolerating full enteral feedings.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
